All
Results: 15601-15612 of 78288

Aduro Clean Technologies Announces Closing of Underwriter’s Over-Allotment Option in Public Offering

Chiesi Global Rare Diseases and Protalix BioTherapeutics Receive Positive CHMP Opinion for an Additional Dosing Regimen of 2mg/kg Body Weight Every-Four-Weeks for Elfabrio® (pegunigalsidase alfa) ▼ in the EU








